All In Biotech

Free tool

FAERS Monitor: Ascor

The FDA Adverse Event Reporting System collects reports from patients, clinicians and manufacturers. Counts are unverified reports, not rates: they rise with how widely a drug is used, how long it has been sold and media attention, a report can name several drugs, and a report does not show the drug caused the event.

Last checked: Nov 20, 2026FDA FAERS (openFDA) last updated: Oct 28, 2026Methods & limitations

Reports naming NDA 209112 or its brand name (Ascor, Ascorbic Acid). Reports on generic versions are filed under their own applications.

Reports

23,363

Serious

16,695

71% of reports

Hospitalization

9,339

Death reported

2,648

Any cause; not necessarily from the drug

Most reported reactions

MedDRA preferred terms.

  • fatigue2,366
  • pain2,120
  • nausea2,025
  • diarrhoea1,860
  • headache1,830
  • drug ineffective1,800
  • dyspnoea1,711
  • off label use1,601
  • vomiting1,585
  • asthenia1,491
  • rash1,425
  • dizziness1,363
  • arthralgia1,300
  • pruritus1,166
  • pyrexia1,162

Reports by year received

View as table
YearReports
2004369
2005810
2006875
2007890
20081,126
20091,295
20101,093
20111,802
20121,842
2013428
2014485
2015493
2016661
2017794
20181,056
20191,037
20201,325
20211,279
20221,328
20231,222
20241,306
20251,093
2026753

Disproportionality screen

Proportional reporting ratio (PRR): how much more often each reaction appears in this drug's reports than in the other 21,030,796 FAERS reports. Flagged when PRR is at least 2, chi-squared at least 4 and there are 3 or more reports (Evans criteria). A screening statistic only.

ReactionReportsPRR95% CI lowerChi-squared
astheniaSignal1,4913.63.42,809
painSignal2,1203.13.03,122
vomitingSignal1,5853.02.92,212
pyrexiaSignal1,1623.02.91,599
rashSignal1,4252.92.81,867
arthralgiaSignal1,3002.82.71,552
fatigueSignal2,3662.72.62,707
pruritusSignal1,1662.72.61,303
dyspnoeaSignal1,7112.72.61,914
headacheSignal1,8302.62.51,902
diarrhoeaSignal1,8602.62.51,880
dizzinessSignal1,3632.52.31,210
nauseaSignal2,0252.32.21,552
off label use1,6011.61.6423
drug ineffective1,8001.21.282

A high PRR for a reaction that is also the condition being treated (for example "disease progression" for a cancer drug) is expected and is not a safety signal.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.